FDA commissioner's blog on Modeling and Simulation

2 messages 2 people Latest: Aug 01, 2017

FDA commissioner's blog on Modeling and Simulation

From: Yaning Wang Date: July 29, 2017 technical
Dear Colleagues: We should feel proud of what we do. Please see the encouraging blog from the FDA commissioner, Dr. Scott Gottlieb. https://blogs.fda.gov/fdavoice/index.php/2017/07/how-fda-plans-to-help-consumers-capitalize-on-advances-in-science/ Yaning Wang, Ph.D. Acting Director Division of Pharmacometrics Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research Food and Drug Administration Phone: 301-796-1624 Email: [email protected] Disclaimer: The contents of this message are mine personally and do not necessarily reflect any position of the Government or the Food and Drug Administration.

Re: FDA commissioner's blog on Modeling and Simulation

From: Holly Kimko Date: August 01, 2017 technical
Hi I wonder when the other variables (DVID>1) will be available. I see that IRP had been included but cannot find Nab (neutralizing antibody). May I have that variable values? Best, Holly
Quoted reply history
On Jul 29, 2017, at 4:27 PM, Wang, Yaning <[email protected]<mailto:[email protected]>> wrote: Dear Colleagues: We should feel proud of what we do. Please see the encouraging blog from the FDA commissioner, Dr. Scott Gottlieb. https://blogs.fda.gov/fdavoice/index.php/2017/07/how-fda-plans-to-help-consumers-capitalize-on-advances-in-science/ Yaning Wang, Ph.D. Acting Director Division of Pharmacometrics Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research Food and Drug Administration Phone: 301-796-1624 Email: [email protected]<mailto:[email protected]> Disclaimer: The contents of this message are mine personally and do not necessarily reflect any position of the Government or the Food and Drug Administration.